• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

先前未参与者的参与不能完全弥补第二轮 FIT 筛查中较低的参与率。

Involvement of previous non-participants cannot fully compensate for lower participation in a second round of FIT-screening.

机构信息

Department of Gastroenterology and Hepatology, Academic Medical Centre, Amsterdam, The Netherlands.

出版信息

Cancer Epidemiol. 2013 Jun;37(3):330-5. doi: 10.1016/j.canep.2013.01.007. Epub 2013 Feb 9.

DOI:10.1016/j.canep.2013.01.007
PMID:23403127
Abstract

INTRODUCTION

The effectiveness of colorectal cancer (CRC) screening programs depends on repeated participation. Little is known on later rounds in programs that use the fecal immunochemical test (FIT), in particular whether previous participants are likely to participate again, and if non-participants persist in declining. We compared overall participation in a second round to that in a first round, and evaluated differences in participation rates based on previous response.

METHODS

Asymptomatic persons aged 50-74 years were invited to a second round of a FIT-based CRC screening pilot. We assessed the participation rate overall and within second round subgroups of previous participants, previous non-participants, and first time invitees. We also assessed whether participation rates were similar for males and females and for age groups.

RESULTS

In the first screening round, 2871 of 5309 invitees returned the FIT (participation rate of 57%). This was higher than in the second in which 3187 of 5925 participated (54%; p = 0.0008). Second round participation rate was 85% (2034/2385) among previous participants, 18% (325/1826) among previous non-participants and 48% (828/1714) among first time invitees (p < .0001). Overall, males and persons aged under 55 were less likely to participate.

CONCLUSIONS

Participation in a second round of FIT-screening was significantly lower than in the first round, largely due to a drop in participation in first round participants, and a relatively low response among first time invitees. This loss of uptake was partially compensated by a willingness to be screened in previous non-participants.

摘要

简介

结直肠癌(CRC)筛查计划的有效性取决于重复参与。在使用粪便免疫化学试验(FIT)的计划的后续轮次中,人们对其了解甚少,特别是之前的参与者是否有可能再次参与,以及未参与者是否继续拒绝。我们比较了第二轮的总体参与率与第一轮的参与率,并根据之前的反应评估了参与率的差异。

方法

邀请 50-74 岁的无症状者参加基于 FIT 的 CRC 筛查试验的第二轮。我们评估了第二轮的总体参与率,以及第一轮的既往参与者、既往未参与者和首次受邀者的第二轮亚组的参与率。我们还评估了男性和女性以及不同年龄组的参与率是否相似。

结果

在第一轮筛查中,5309 名受邀者中有 2871 人返回了 FIT(参与率为 57%)。这高于第二轮的 5925 名受邀者中有 3187 人参与(参与率为 54%;p = 0.0008)。第二轮的既往参与者参与率为 85%(2034/2385),既往未参与者为 18%(325/1826),首次受邀者为 48%(828/1714)(p <.0001)。总体而言,男性和 55 岁以下的人不太可能参与。

结论

FIT 筛查第二轮的参与率明显低于第一轮,主要是由于第一轮参与者的参与率下降,以及首次受邀者的相对低响应率。这种参与率的下降部分被以前未参与者愿意接受筛查所补偿。

相似文献

1
Involvement of previous non-participants cannot fully compensate for lower participation in a second round of FIT-screening.先前未参与者的参与不能完全弥补第二轮 FIT 筛查中较低的参与率。
Cancer Epidemiol. 2013 Jun;37(3):330-5. doi: 10.1016/j.canep.2013.01.007. Epub 2013 Feb 9.
2
Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.粪便检测阴性的结直肠癌患者发生高级别腺瘤风险较低。
Gastroenterology. 2012 Mar;142(3):497-504. doi: 10.1053/j.gastro.2011.11.024. Epub 2011 Nov 19.
3
Attendance and yield over three rounds of population-based fecal immunochemical test screening.三轮基于人群的粪便免疫化学检测筛查的参与率和阳性率。
Am J Gastroenterol. 2014 Aug;109(8):1257-64. doi: 10.1038/ajg.2014.168. Epub 2014 Jul 1.
4
What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?影响人们决定参与粪便潜血试验和乙状结肠镜检查进行结直肠癌筛查的因素有哪些?
Eur J Cancer. 2013 Jul;49(10):2321-30. doi: 10.1016/j.ejca.2013.03.007. Epub 2013 Apr 6.
5
The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut-off level on yield of screening.荷兰结直肠癌筛查项目第二轮:粪便免疫化学检测截断值提高对筛查效果的影响。
Int J Cancer. 2020 Aug 15;147(4):1098-1106. doi: 10.1002/ijc.32839. Epub 2020 Jan 9.
6
Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.多次粪便免疫化学检测受试者的间期结直肠癌发病率。
Gastroenterology. 2017 Aug;153(2):439-447.e2. doi: 10.1053/j.gastro.2017.05.004. Epub 2017 May 5.
7
Adherence to colorectal cancer screening: four rounds of faecal immunochemical test-based screening.结直肠癌筛查的依从性:四轮基于粪便免疫化学检测的筛查
Br J Cancer. 2017 Jan 3;116(1):44-49. doi: 10.1038/bjc.2016.399. Epub 2016 Dec 6.
8
Participation, yield, and interval carcinomas in three rounds of biennial FIT-based colorectal cancer screening.三轮基于粪便免疫化学检测(FIT)的两年一次的结直肠癌筛查中的参与率、检出率和间隔期癌
Cancer Epidemiol. 2015 Jun;39(3):388-93. doi: 10.1016/j.canep.2015.03.012. Epub 2015 Apr 21.
9
Implementation of population screening for colorectal cancer by repeated Fecal Immunochemical Test (FIT): third round.重复粪便免疫化学试验(FIT)进行结直肠癌人群筛查的实施:第三轮。
BMC Gastroenterol. 2012 Jun 19;12:73. doi: 10.1186/1471-230X-12-73.
10
Sustained participation, colonoscopy uptake and adenoma detection rates over two rounds of the Tallaght-Trinity College colorectal cancer screening programme with the faecal immunological test.在两轮塔拉赫特-三一学院结直肠癌筛查项目中,采用粪便免疫检测法的持续参与率、结肠镜检查接受率及腺瘤检出率。
Eur J Gastroenterol Hepatol. 2014 Dec;26(12):1415-21. doi: 10.1097/MEG.0000000000000207.

引用本文的文献

1
What can We Learn From High-Performing Screening Programs to Increase Bowel Cancer Screening Participation in Australia?从表现优异的筛查项目中,我们可以学到哪些经验来提高澳大利亚的结直肠癌筛查参与率?
Cancer Control. 2022 Jan-Dec;29:10732748221121383. doi: 10.1177/10732748221121383.
2
Selection of patients for large mailed fecal immunochemical test colorectal cancer screening outreach programs: A systematic review.大规模邮寄粪便免疫化学试验用于结直肠癌筛查外展项目的患者选择:系统评价。
J Med Screen. 2021 Dec;28(4):379-388. doi: 10.1177/0969141321997482. Epub 2021 Mar 8.
3
A Systematic Review of Repeat Fecal Occult Blood Tests for Colorectal Cancer Screening.
用于结直肠癌筛查的重复粪便潜血试验的系统评价
Cancer Epidemiol Biomarkers Prev. 2020 Feb;29(2):278-287. doi: 10.1158/1055-9965.EPI-19-0775. Epub 2019 Nov 18.
4
Factors Affecting Adherence in a Pragmatic Trial of Annual Fecal Immunochemical Testing for Colorectal Cancer.影响年度粪便免疫化学试验用于结直肠癌的实用临床试验依从性的因素。
J Gen Intern Med. 2019 Jun;34(6):978-985. doi: 10.1007/s11606-018-4820-0. Epub 2019 Jan 25.
5
Adherence to colorectal cancer screening: four rounds of faecal immunochemical test-based screening.结直肠癌筛查的依从性:四轮基于粪便免疫化学检测的筛查
Br J Cancer. 2017 Jan 3;116(1):44-49. doi: 10.1038/bjc.2016.399. Epub 2016 Dec 6.
6
Resilience of a FIT screening programme against screening fatigue: a modelling study.粪便免疫化学检测筛查项目抵御筛查疲劳的能力:一项建模研究
BMC Public Health. 2016 Sep 22;16(1):1009. doi: 10.1186/s12889-016-3667-8.
7
Veterans' Continued Participation in an Annual Fecal Immunochemical Test Mailing Program for Colorectal Cancer Screening.退伍军人持续参与年度粪便免疫化学检测邮寄计划以进行结直肠癌筛查。
J Am Board Fam Med. 2015 Jul-Aug;28(4):494-7. doi: 10.3122/jabfm.2015.04.140241.
8
Predictors of repeat participation in the NHS bowel cancer screening programme.英国国家医疗服务体系(NHS)肠癌筛查项目重复参与的预测因素。
Br J Cancer. 2015 Jan 6;112(1):199-206. doi: 10.1038/bjc.2014.569. Epub 2014 Nov 27.
9
Behavioural and demographic predictors of adherence to three consecutive faecal occult blood test screening opportunities: a population study.连续三次粪便潜血试验筛查机会依从性的行为和人口统计学预测因素:一项人群研究。
BMC Public Health. 2014 Mar 7;14:238. doi: 10.1186/1471-2458-14-238.